These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16997553)

  • 1. Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations.
    Nudelman I; Rebibo-Sabbah A; Shallom-Shezifi D; Hainrichson M; Stahl I; Ben-Yosef T; Baasov T
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6310-5. PubMed ID: 16997553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminoglycosides redesign strategies for improved antibiotics and compounds for treatment of human genetic diseases.
    Pokrovskaya V; Nudelman I; Kandasamy J; Baasov T
    Methods Enzymol; 2010; 478():437-62. PubMed ID: 20816493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases.
    Hainrichson M; Nudelman I; Baasov T
    Org Biomol Chem; 2008 Jan; 6(2):227-39. PubMed ID: 18174989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system.
    Keeling KM; Bedwell DM
    J Mol Med (Berl); 2002 Jun; 80(6):367-76. PubMed ID: 12072912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Readthrough of dystrophin stop codon mutations induced by aminoglycosides.
    Howard MT; Anderson CB; Fass U; Khatri S; Gesteland RF; Atkins JF; Flanigan KM
    Ann Neurol; 2004 Mar; 55(3):422-6. PubMed ID: 14991821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repairing faulty genes by aminoglycosides: development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations.
    Nudelman I; Glikin D; Smolkin B; Hainrichson M; Belakhov V; Baasov T
    Bioorg Med Chem; 2010 Jun; 18(11):3735-46. PubMed ID: 20409719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoglycoside-induced translational read-through in disease: overcoming nonsense mutations by pharmacogenetic therapy.
    Zingman LV; Park S; Olson TM; Alekseev AE; Terzic A
    Clin Pharmacol Ther; 2007 Jan; 81(1):99-103. PubMed ID: 17186006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The minor gentamicin complex component, X2, is a potent premature stop codon readthrough molecule with therapeutic potential.
    Friesen WJ; Johnson B; Sierra J; Zhuo J; Vazirani P; Xue X; Tomizawa Y; Baiazitov R; Morrill C; Ren H; Babu S; Moon YC; Branstrom A; Mollin A; Hedrick J; Sheedy J; Elfring G; Weetall M; Colacino JM; Welch EM; Peltz SW
    PLoS One; 2018; 13(10):e0206158. PubMed ID: 30359426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational readthrough induction of pathogenic nonsense mutations.
    Kellermayer R
    Eur J Med Genet; 2006; 49(6):445-50. PubMed ID: 16740421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sense from nonsense: therapies for premature stop codon diseases.
    Bidou L; Allamand V; Rousset JP; Namy O
    Trends Mol Med; 2012 Nov; 18(11):679-88. PubMed ID: 23083810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stop-codon read-through for patients affected by a lysosomal storage disorder.
    Brooks DA; Muller VJ; Hopwood JJ
    Trends Mol Med; 2006 Aug; 12(8):367-73. PubMed ID: 16798086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of paromomycin-related heterocycle-substituted aminoglycoside mimetics based on a mass spectrometry RNA-binding assay.
    Ding Y; Hofstadler SA; Swayze EE; Risen L; Griffey RH
    Angew Chem Int Ed Engl; 2003 Jul; 42(29):3409-12. PubMed ID: 12888972
    [No Abstract]   [Full Text] [Related]  

  • 13. Aminoglycosides and other factors promoting stop codon readthrough in human cells.
    Diop D; Chauvin C; Jean-Jean O
    C R Biol; 2007 Jan; 330(1):71-9. PubMed ID: 17241950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of aromatic rings in the molecular recognition of aminoglycoside antibiotics: implications for drug design.
    Vacas T; Corzana F; Jiménez-Osés G; González C; Gómez AM; Bastida A; Revuelta J; Asensio JL
    J Am Chem Soc; 2010 Sep; 132(34):12074-90. PubMed ID: 20698528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential selectivity of natural and synthetic aminoglycosides towards the eukaryotic and prokaryotic decoding A sites.
    Kondo J; Hainrichson M; Nudelman I; Shallom-Shezifi D; Barbieri CM; Pilch DS; Westhof E; Baasov T
    Chembiochem; 2007 Sep; 8(14):1700-9. PubMed ID: 17705310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pattern of distribution of amino groups modulates the structure and dynamics of natural aminoglycosides: implications for RNA recognition.
    Corzana F; Cuesta I; Freire F; Revuelta J; Torrado M; Bastida A; Jiménez-Barbero J; Asensio JL
    J Am Chem Soc; 2007 Mar; 129(10):2849-65. PubMed ID: 17298063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antibacterial activity of novel neamine derivatives.
    Minowa N; Akiyama Y; Hiraiwa Y; Maebashi K; Usui T; Ikeda D
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6351-4. PubMed ID: 16997557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMRT compounds correct nonsense mutations in primary immunodeficiency and other genetic models.
    Gatti RA
    Ann N Y Acad Sci; 2012 Feb; 1250():33-40. PubMed ID: 22364446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoglycoside antibiotics: old drugs and new therapeutic approaches.
    Hermann T
    Cell Mol Life Sci; 2007 Jul; 64(14):1841-52. PubMed ID: 17447006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of generic immunoassay for the detection of a series of aminoglycosides with 6'-OH group for the treatment of genetic diseases in biological samples.
    Shalev M; Kandasamy J; Skalka N; Belakhov V; Rosin-Arbesfeld R; Baasov T
    J Pharm Biomed Anal; 2013 Mar; 75():33-40. PubMed ID: 23312382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.